Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · 2008 · 10 citations · 28 references
Heart FailureEmergency CabgEndovascular TechniqueSurgeryCoronary Artery DiseaseAcute Myocardial InfarctionVascular SurgeryPrevious CabgPublic HealthAtherosclerosisCardiologyCardiovascular ImagingMyocardial InfarctionPercutaneous Coronary InterventionLate AngioplastyDifferences Between EarlyOutcomes ResearchRecurrent IschemiaCardiovascular DiseaseCoronary UnitMedicineEmergency MedicineAnesthesiology
The aim of the present study was to identify patients with recurrent ischemia after coronary artery bypass surgery (CABG) treated by percutaneous coronary intervention (PCI). Graft failure after CABG may be managed conservatively or treated by surgery or PCI. We thought to investigate clinical, angiographic, and procedural characteristics in relation to clinical outcome. This was a retrospective single-center study. Patients who underwent revascularization by PCI with a previous CABG were analyzed. Patients were divided in 3 groups, depending on interval between CABG and index PCI: group 1, interval <72 hours; group 2, interval between 72 hours and 1 year; group 3, interval >1 year. Two hundred twenty-one patients were studied. Clinical characteristics and survival curves were comparable in groups 2 and 3. Postoperative creatine kinase MB and troponin values were significantly higher in group 1 (P = 0.000). From group 1, significantly more patients (10.5%) required emergency CABG after the index PCI than compared with group 2 (2.1%) and group 3 (0%), (P = 0.003). There were more off-pump CABGs in group 1 than in the other 2 groups. Group 1 received less PCIs in native ungrafted vessels compared with the other 2 groups. Mortality in group 1 (18.4%) was higher than in the other 2 groups (7.4 and 4.5%, respectively; P < 0.05). Mortality in group 1 was higher in the acute phase of follow-up. PCI performed less than 72 hours after CABG is feasible but accompanied by a higher mortality and redo CABG. This outcome is probably related to the high-risk patient category.
28
The Prognostic Value of Serum Troponin T in Unstable Angina
Christian W. Hamm, Jan Ravkilde, W. Gerhardt et al. · New England Journal of Medicine · 1992 · 963 citations
Eric J. Topol, R.M. Califf, Harlan F. Weisman et al. · The Lancet · 1994 · 840 citations
Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +15
Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents
J. Eduardo Sousa, Marco A. Costa, Alexandre Abizaid et al. · Circulation · 2001 · 667 citations · Full text